Page 1

Арух MEDICAL Energy Elevating Lives EXHIBIT 99.1 Apyx Medical Corporation Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Outlook Advanced Energy Sales increased 88 % year - over - year in Q3 CLEARWATER , FL _ November 11 , 2021 - Apyx Medical Corporation ( NASDAQ : APYX ) ( the “ Company ” ) , a maker of medical devices and supplies and the developer of Helium Plasma Technology , marketed and sold as Renuvion® in the cosmetic surgery market and J- PlasmaⓇ in the hospital surgical market , today reported financial results for its third quarter ended September 30 , 2021 and updated its financial outlook for the full year ending December 31 , 2021 . Third Quarter 2021 Financial Summary : • • • Total revenue of $ 11.8 million , up 70 % year - over - year . о ° OEM revenue of $ 1.5 million , up 3 % year - over - year . • Advanced Energy revenue of $ 10.3 million , up 88 % year - over - year . Net loss attributable to stockholders of $ 4.2 million , compared to net loss attributable to stockholders of $ 3.7 million for the third quarter of 2020. Net loss attributable to stockholders in the third quarter of 2020 included an income tax benefit of $ 0.7 million . Adjusted EBITDA loss of $ 2.7 million , compared to adjusted EBITDA loss of $ 3.1 million for the third quarter of 2020 . At September 30 , 2021 , the Company had cash and cash equivalents of $ 30.9 million , compared to $ 41.9 million as of December 31 , 2020. At September 30 , 2021 , the Company had working capital of $ 48.2 million , including expected cash tax refunds of approximately $ 7.5 million the Company expects to receive during 2021 or 2022 related to the net operating loss carrybacks resulting from the 2020 CARES Act . Third Quarter 2021 Operating Highlights : • On August 30 , 2021 , the Company announced the appointment of Wendy Levine to the Board of Directors , effective August 25 , 2021. Ms. Levine serves as a Director and member of the Regulatory Compliance Committee . Management Comments : “ We are excited by our team's impressive execution during the third quarter , which enabled us to achieve 88 % growth year - over - year in sales of our Advanced Energy products . Our Advanced Energy sales growth was driven primarily by strong , global utilization of our Advanced Energy handpieces , with global handpiece sales increasing more than 100 % year - over - year . We also saw global Advanced Energy generator sales increase by more than 70 % year - over - year , primarily reflecting healthy adoption of our Renuvion® technology in the U.S. cosmetic surgery market . " Mr. Goodwin continued : “ We are raising our 2021 financial outlook today in light of our stronger - than - anticipated performance that we achieved in the third quarter . Looking ahead , our financial outlook continues to reflect our expectations for continued improvement in the global capital equipment environment , coupled with strong utilization trends from our existing customers , during the fourth quarter . We expect to bring 2021 to a strong close as we continue to raise awareness of our innovative Helium Plasma Technology , expand our share of the multi - billion global cosmetic surgery market and enhance the foundation for strong , sustainable growth in the years ahead . "